NAD+ Therapy
Nicotinamide adenine dinucleotide or its precursors, intended to support cellular energy metabolism, positioned honestly as an area of active research.
What it is & how it works
NAD+ Therapy delivers nicotinamide adenine dinucleotide or its metabolic precursors, intended to support cellular energy metabolism and mitochondrial function. NAD+ is a coenzyme involved in numerous cellular processes, including pathways studied in aging research (e.g. sirtuin activity), though human clinical evidence lags behind preclinical interest.
How it's done
Typically administered intravenously over an extended infusion (commonly several hours per session) or via subcutaneous injection, depending on protocol and dose. An initial course of consecutive or closely spaced sessions is common, followed by an individualized maintenance schedule.
Conditions it treats
Why Unfold Longevity
Positioned honestly as an area of active research rather than a proven anti-ageing therapy, in keeping with Unfold Longevity's commitment to evidence-bounded language and not overstating an emerging modality.
Evidence & safety
Evidence in humans is still developing relative to preclinical data. Its use for Rejuvenation is provisional, pending scope confirmation.
Related questions
Human clinical evidence for NAD+ infusions remains limited — most published data come from small pilot or tolerability studies rather than large randomized trials, and it is not an FDA-approved treatment for any medical condition. It is positioned here as an area of active research rather than a proven therapy.
No. NAD+ is involved in cellular energy metabolism and pathways studied in ageing research, but no clinical trial has established that NAD+ infusions slow ageing or reliably boost energy in humans, and no such outcome is promised.